+++thanks4 more articles fromfuturemedchem & 1 from springer

[pendyala123]

1. Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challengesMoni Sharma and Prem MS ChauhanFuture Medicinal Chemistry, June 2012, Vol. 4, No. 10 , Pages 1335-1365

DOI:

http://dx.doi.org/10.4155/fmc.12.68

Код: Выделить всё

http://www.future-science.com/doi/pdf/10.4155/fmc.12.68

2.Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-triazine-based heterocyclesRahul V Patel, Premlata Kumari, Dhanji P Rajani, Christophe Pannecouque, Erik De Clercq, and Kishor H ChikhaliaFuture Medicinal Chemistry, June 2012, Vol. 4, No. 9 , Pages 1053-1065

DOI:

http://dx.doi.org/10.4155/fmc.12.57

Код: Выделить всё

http://www.future-science.com/doi/pdf/10.4155/fmc.12.57

3.Recent development of small antimicrobial peptidomimeticsYouhong Niu, Rongsheng E Wang, Haifan Wu, and Jianfeng CaiFuture Medicinal Chemistry, September 2012, Vol. 4, No. 14 , Pages 1853-1862

DOI:

http://dx.doi.org/10.4155/fmc.12.111

Код: Выделить всё

http://www.future-science.com/doi/pdf/10.4155/fmc.12.111

4.Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugsJingxin Wang, Ryan Hudson, and Herman O Sintim Future Medicinal Chemistry, June 2012, Vol. 4, No. 9 , Pages 1113-1151

DOI:

http://dx.doi.org/10.4155/fmc.12.62

Код: Выделить всё

http://www.future-science.com/doi/pdf/10.4155/fmc.12.62

5. Targeting tuberculosis through a small focused library of 1,2,3-triazolesGuillermo R. Labadie, Agustina de la Iglesia, Héctor R. Morbidoni
Molecular Diversity November 2011, Volume 15, Issue 4, pp 1017-1024

DOI:

http://dx.doi.org/10.1007/s11030-011-9319-0

Код: Выделить всё

http://link.springer.com/article/10.1007/s11030-011-9319-0

[Франсин]

№5

[macro]

1,2,4